Stay updated on Her2 Therapy & Pembrolizumab in Neoadjuvant Clinical Trial

Sign up to get notified when there's something new on the Her2 Therapy & Pembrolizumab in Neoadjuvant Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Her2 Therapy & Pembrolizumab in Neoadjuvant Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    Updated the page revision from v3.6.3 to v3.6.4 to reflect a maintenance update. This change represents a metadata/version bump and does not affect the study content or user-facing features.
    Difference
    0.0%
    Check dated 2026-07-28T14:58:58.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The study record shows new timestamps reflecting recent maintenance: last update posted on 2026-07-08 and last update submitted on 2026-06-12, along with a June 2026 entry. This indicates routine record upkeep rather than changes to the study details.
    Difference
    0.2%
    Check dated 2026-07-14T10:06:03.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.0 to v3.6.3 to reflect a newer page build. This change does not alter visible content, study details, or user-facing features.
    Difference
    0.0%
    Check dated 2026-06-30T01:45:33.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Added a recruitment status note indicating enrollment is closed. Added/standardized navigation and help-content sections (How to Read a Study Record, Common Questions, How to Join a Study, Intervention/Treatment) and removed the older 'Intervention / Treatment' label to align with a site-wide formatting update.
    Difference
    0.4%
    Check dated 2026-06-15T20:52:32.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The site now shows Revision: v3.5.5, replacing the previous Revision: v3.5.4. This indicates a recent software update to the platform and does not alter the study details or page content.
    Difference
    0.0%
    Check dated 2026-06-08T17:16:27.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    The page's revision is updated from v3.5.3 to v3.5.4, indicating a new version of the page. This typically reflects minor edits or metadata adjustments in the page history.
    Difference
    0.0%
    Check dated 2026-05-18T04:00:09.000Z thumbnail image

Stay in the know with updates to Her2 Therapy & Pembrolizumab in Neoadjuvant Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Her2 Therapy & Pembrolizumab in Neoadjuvant Clinical Trial page.